As the one-size-fits-all paradigm of cancer care continues to fade, treatment selection that is informed by the unique molecular profile of an individual’s tumor is an established route to improving patient treatment outcomes. We are observing improved standardization of precision oncology practices and greater patient access to individually tailored cancer care across healthcare settings.

However, this is not universal, and many patients are still denied optimal therapy due to a lack of testing. 

As we complete the foundational work across several major projects in 2024, the PCC will continue to build on these foundations to maximize patient impact in 2025 and beyond.  Our vision is to make precision oncology and CGP the new normal – only together can we achieve this. 

Click on the image, or button to download the annual report.